B
ruton's tyrosine kinase (Btk) 3 belongs to the Tec family of cytoplasmic protein tyrosine kinases and plays an essential role in B lymphocyte development and function (1, 2) . In mature B cells, Btk is tyrosine phosphorylated and its kinase activity is increased upon B cell receptor (BCR) stimulation (3) (4) (5) .
Mutations in the Btk gene lead to X-linked agammaglobulinaemia (XLA) in humans and X-linked immunodeficiency (xid) in the mouse (6 -9) . XLA is characterized by recurrent bacterial infections, and very low serum Ig levels of all classes due to the lack of plasma cells in the secondary lymphoid organs. There is a severe deficiency of peripheral B cells, and those B cells that are present have an aberrant IgM high phenotype (10) . In the bone marrow (BM) of XLA patients, the numbers of cytoplasmic H chain (c)-expressing pre-B cells are variable, but in most cases reduced; those pre-B cells present are mainly nonproliferating small cells (11) (12) (13) . The absence of Btk apparently results in deficient expansion of the earliest c-expressing pre-B cells. Therefore, the XLA disease phenotype most likely reflects defective signaling through the pre-BCR, by which the expression of a functional H chain normally is monitored, together with surrogate L chain (SLC; Ref. 14) . As most patients have substantial numbers of pro-B cells in their BM, XLA generally results in an increased ratio of pro-B to pre-B cells (11) (12) (13) .
In contrast, Btk deficiency in the mouse is associated with an impairment of peripheral B cell maturation, without a major early B cell developmental block (15) (16) (17) . In xid mice the mature IgM low IgD high B cell populations in spleen and lymph nodes are severely reduced, B-1 B cells are absent, and serum IgM and IgG3 levels are low. Xid B cells do not proliferate upon surface IgM (sIgM) stimulation. The most obvious difference between the BM B cell compartment of wild-type (WT) mice and Btk-deficient mice is the reduction in mature recirculating cells (15) (16) (17) . The absolute numbers of pre-B cells that are generated in the BM of Btk-deficient mice are normal, and Btk-deficient B cell precursors in the BM have the same kinetics of turnover (18, 19) . Nevertheless, several lines of evidence point at a role for Btk at the transition of pre-B cells into immature surface Ig ϩ B cells, thereby indicating the involvement of Btk in pre-BCR signaling in the mouse. Using an in vivo competition assay in heterozygous Btk ϩ/Ϫ female mice, we identified a small but significant selective disadvantage of Btk-deficient cells to contribute to the IgM ϩ IgD Ϫ immature B cells stage in the BM (17) . Our recent finding of an intrinsic reduction of Ig L chain usage in Btk-deficient B cells in the mouse implicated Btk in the activation of gene rearrangements at the L chain locus (20) . Furthermore, while mice deficient for another Tec kinase family member, Tec, showed normal B cell development, an almost complete block at the CD43 ϩ B220 ϩ stage of B cell development was observed in Btk/Tec double-deficient mice (21) . These results indicated that Btk is critically involved in pre-BCR-mediated signaling in the mouse and that Tec is able to compensate for the loss of Btk during early B cell development. A role for Btk in pre-BCR signaling would be consistent with the recent finding that Btk is able to function in CD79b (Ig␤)-mediated signaling in recombination-activating gene (RAG)-2-deficient pro-B cells (22) .
To examine the role of Btk at the pre-BCR checkpoint in vivo, we compared the expression of early B cell surface markers in the BM from Btk-deficient and WT control mice. In this report, we show that Btk is involved in the pre-BCR-dependent induction of cell surface phenotype changes during the progression of large cycling c ϩ pre-B cells into surface Ig ϩ immature B cells, thereby affecting the transit time through the small pre-B cell compartment. In addition, we performed IL-7-driven BM cultures, which point at a role for Btk in the differentiation stage-specific modulation of IL-7 responsiveness in early murine B cell development, even in stages preceding c expression.
Materials and Methods

Mice and genotyping
Btk
Ϫ /lacZ mice (17) were crossed onto a C57BL/6 background for Ͼ6 generations. Specific experiments were additionally performed with Btk mice on a mixed C57BL/6 ϫ 129 or C57BL/6 ϫ FVB background, but no significant influence of the genetic background was observed. RAG-1 Ϫ/Ϫ mice (23) were on a 129/Sv background. All mice were bred and maintained in the animal care facility at the Erasmus Medical Center, Rotterdam (Rotterdam, The Netherlands). To determine the Btk genotype, tail DNA was analyzed by Southern blotting of BamHI digests, as described (17) . The RAG-1 genotype was determined using a 1.9-kb partial RAG-1 probe (encoding amino acid positions 387-1008, kindly provided by D. van Gent, Erasmus Medical Center) to hybridize to BamHI-NcoI genomic digests (23) .
Flow cytometric analysis
Preparations of single-cell suspensions, flow cytometry, and determination of ␤-galactosidase activity by loading cells with fluorescein-di-␤-D-galactopyranoside substrate (Molecular Probes Europe, Leiden, The Netherlands), have previously been described (17, 24) . Events (1Ϫ3 ϫ 10 5 ) were scored using a FACSCalibur flow cytometer and analyzed by CellQuest software (BD Biosciences, Mountain View, CA). The following mAbs were obtained from BD PharMingen (San Diego, CA): FITC-conjugated anti-BP-1/6C3, anti-B220/RA3-6B2, anti-(R5-240), and anti-IgM (II/41); PE-conjugated anti-CD2, anti-(187.1), anti-CD25, and anti-CD43; CyChrome-conjugated anti-B220/RA3-6B2 and biotinylated anti-IL7R, anti-(187.1), anti-1 / 2 (R26-46), and anti-IgM (II/41). PE-conjugated IgD was obtained from Southern Biotechnology Associates (Birmingham, AL). Biotinylated anti-SLC Ab LM34 (25) was kindly provided by A. Rolink (Basel Institute for Immunology, Basel, Switzerland). Secondary Abs were PE-, tricolor-, or APC-conjugated streptavidin, purchased from Caltag Laboratories (Burlingame, CA).
For intracellular flow cytometric detection of cytoplasmic Ig H or L chain or SLC, the following Abs were applied: FITC-conjugated anti-Ig (R5-240, BD PharMingen) or polyclonal anti-Ig H chain (Jackson Immunoresearch Laboratories, West Grove, PA) and biotinylated anti-1 / 2 (BD PharMingen), or anti-SLC (LM34). Cells were first stained for cell surface markers and subsequently fixed in 2% paraformaldehyde and permeabilized using 0.5% saponin.
Cell cycle analysis
To analyze cell cycle status of cultured cell suspensions, cells were incubated in ice-cold ethanol for Ͼ2 h. Subsequently, cells were incubated at room temperature for 30 min in PBS containing 0.02 mg/ml propidium iodide, 0.1% v/v Triton X-100, and 0.2 mg/ml RNase, left overnight at 4°C, and analyzed with a FACSCalibur flow cytometer. Doublet cells were excluded from the analysis by measuring peak area and width. For simultaneous analysis of cell surface markers, c expression, and DNA content, we used a method described by Constantinescu and Schlissel (26) . Cells were sequentially stained for surface CD2 expression using PE-labeled anti-CD2, for c using polyclonal anti-H chain, and 7-aminoactinomycin-D (7-AAD, Molecular Probes Europe).
IL-7-driven BM cultures
Primary pre-B cell cultures were essentially performed as described previously (20) , using erythrocyte-depleted total BM cell suspensions. For specific experiments, BM cell suspensions were depleted of sIgM ϩ cells, using biotinylated anti-IgM and streptavidin-coated microbeads, as described (20) . Recombinant murine IL-7 was from R&D Systems (Minneapolis, MN). To measure IL-7-dependent proliferative responses, cells were cultured in flat-bottom 96-well plates for 5 days with various amounts of IL-7 at different cell concentrations (0.25-1 ϫ 10 5 cells/well). Cultures were pulsed for 24 h with 0.5 Ci/well of [ 3 H]thymidine, harvested on glass-fiber filters, and the incorporated radioactivity was determined using a beta counter, according to standard procedures.
In vivo 5-bromo-2Ј-deoxyuridine (BrdU) labeling
BrdU (Sigma Aldrich, St. Louis, MO) was dissolved in PBS at 2 mg/ml. Mice were injected i.p. with 200 l, and sacrificed at various time points. Total BM cell suspensions were analyzed by flow cytometry for BrdU incorporation, using the BrdU flow kit (BD PharMingen) in conjunction with cell surface marker expression. (Fig. 1A) . About one-fifth of all pre-B cells have been reported to express H chain and L chains in their cytoplasm, without depositing IgM on the cell surface (27) . These cells may have down-regulated sIgM expression due to autoantigen binding, or they may produce Ig H and L chains that do not pair (14, 27 (Fig. 1B) . These findings suggest reduced or delayed Ig L chain rearrangement.
Results
Btk
Signaling through the pre-BCR initiates proliferative expansion of those cells with a productively rearranged Ig H chain. Subsequently, these cells progress into small resting pre-B cells that have changed their cell surface phenotype and initiate and L chain rearrangement (14) . Therefore, we analyzed IgM Ϫ B220 ϩ B cell precursors for the expression of several cell surface markers in four-color flow cytometric experiments (Fig. 1C) . In Btk Ϫ mice, the IgM Ϫ B220 ϩ compartment contained a unique subpopulation of CD43 low cells which manifested increased expression of the BP-1 molecule, a metallopeptidase that is selectively induced coincident with IL-7-driven pre-B cell proliferation (28) . As soon as a pre-BCR is expressed, the synthesis of SLC is turned off (29) . However, Btk Ϫ cells had an increase in the fraction of IgM Ϫ B220 ϩ cells that expressed SLC in their cytoplasm, as compared with Btk ϩ cells (Fig. 1C) . In a specific analysis of c ϩ pre-B cells, Btk Ϫ mice showed significantly reduced expression of the IL-2R CD25 (30 Ϯ 6%), and the CD2 adhesion molecule (32 Ϯ 4%), as compared with Btk ϩ mice (66 Ϯ 7% and 70 Ϯ 6%, respectively). These molecules were previously reported to be upregulated upon pre-BCR signaling (30, 31) .
Collectively, these findings indicated that the absence of Btk resulted in a defective progression of
Analysis of the absolute numbers of the various B-lineage subpopulations in the BM (Table I) revealed that in Btk Ϫ mice the size of the total population of CD2 Ϫ c ϩ early pre-B cells was increased with a factor of ϳ2.4, whereas the total population of CD2 ϩ c ϩ late pre-B cells was decreased with a similar factor.
The developmental progression to CD2 ϩ late pre-B cells normally correlates with a change in cell cycle status, from large cycling into small resting pre-B cells (26) . This was confirmed by the finding in Btk ϩ mice of ϳ45% of CD2 Ϫ and ϳ10% of CD2 ϩ c ϩ pre-B cells in S, M, or G 2 phase, using 7-AAD staining for DNA content (Fig. 1C) . In contrast, the CD2 Ϫ c ϩ pre-B cell population in Btk Ϫ mice contained only ϳ23% of cycling cells, i.e., about half the number found in Btk ϩ mice. However, as the size of the total population of CD2 Ϫ c ϩ pre-B cells was increased with a factor ϳ2.4 in Btk Ϫ mice, we conclude that Btk ϩ and Btk Ϫ mice contain comparable numbers of large cycling c ϩ cells (ϳ0.8 ϫ 10 6 cells per hind leg).
In summary, the absence of Btk in pre-BCR signaling resulted in defective down-regulation of CD43 and SLC, defective up-regulation of CD2 and CD25, augmented expression of BP-1, whereas in vivo proliferative expansion of pre-B cells appeared to be unaffected. 
Btk Ϫ cells show a developmental delay within the small pre-B cell compartment in vivo
The inefficient induction of cell surface phenotype changes in Btk Ϫ mice at the pre-B cell stage was still noticeable at the next developmental stage of IgM ϩ immature B cells. As shown by flow cytometric analysis ( Fig. 2A) , IgM ϩ B220 low immature B cells in Btk Ϫ mice manifested lower expression of CD2 (66 Ϯ 5%, n ϭ 9) and CD25 (19 Ϯ 1%, n ϭ 12), compared with immature B cells in Btk ϩ animals (CD2 ϩ : 90 Ϯ 3%, n ϭ 8, and CD25 ϩ : 36 Ϯ 1%, n ϭ 12). In addition, considerable fractions of Btk Ϫ immature B cells expressed surface BP-1 (45 Ϯ 3%, n ϭ 6) or cytoplasmic SLC (13 Ϯ 3%, n ϭ 8), which were not detected in Btk ϩ immature B cells (Ͻ3%; Fig. 2A ).
To investigate whether the inefficient induction of cell surface phenotype changes in Btk Ϫ pre-B and immature B cells would be associated with a delayed developmental progression into IgM ϩ immature B cells, we estimated the transit time through the small pre-B cell compartment. Btk ϩ and Btk Ϫ mice were injected with a single dose of the BrdU thymidine analog, which is specifically incorporated into the DNA of large cycling pre-B cells (32) (33) (34) 
cells (ϳ29 h). In summary, we conclude that in Btk
Ϫ mice the inefficient induction of cell surface phenotype changes in ϩ pre-B cells was accompanied by a specific developmental delay within the small pre-B cell compartment of ϳ3 h. In addition, the immature B cells generated manifest an aberrant surface phenotype.
Btk Ϫ pre-B cells show deficient developmental progression in vitro
To further investigate the role of Btk in the developmental progression of c ϩ pre-B cells and the initiation of Ig L chain expression, IL-7-driven BM culture experiments were performed, as described (35, 36) . Pre-B cells that have a productive Ig H chain rearrangement undergo rapid cell division in response to IL-7. When IgM Ϫ BM cell suspensions from Btk ϩ mice were cultured in the presence of 100 U/ml IL-7 for 5 days, the majority of cells consisted of B220
ϩ IgM Ϫ cells, while a significant fraction matured to sIgM ϩ IgD Ϫ (ϳ10%) or IgM ϩ IgD ϩ B cell stages (ϳ5%) (Fig. 3) . This differentiation into IgM ϩ cells did not result from an IL-7 insufficiency in culture, as it was also present when higher IL-7 concentrations were used. In contrast, only Ͻ5% and Ͻ0.5% of the Btk Ϫ cells exhibited an IgM ϩ IgD Ϫ or IgM ϩ IgD ϩ profile in culture, respectively. Therefore, these findings indicated that Btk signaling supported the progression from pre-B cell to surface Ig ϩ B cell in vitro in the presence of IL-7. Similar differences were observed, when cells were subsequently cultured for 48 h on S17 stroma cells in the presence of IL-7: ϳ30% of Btk ϩ B220 ϩ cells were surface Ig ϩ , but only ϳ5% of Btk Ϫ B220 ϩ cells (Fig. 3) . After removal of IL-7, which strongly induces the cells to exit from cell cycle and to further differentiate (36), significant numbers of sIgM ϩ B cells were generated in the Btk Ϫ BM cultures. Nevertheless, when compared with Btk ϩ B cells, the maturation of Btk Ϫ B cells to the IgM ϩ IgD ϩ stage was reduced (Fig. 3) . Therefore, the analyses of IL-7-driven BM cultures showed that Btk signaling promotes the maturation of pre-B cells into surface Ig 
Btk Ϫ pre-B cells show enhanced IL-7-driven expansion in vitro
Next, we analyzed the kinetics of in vitro B cell development in IL-7-driven BM cultures, using total BM cells from Btk ϩ , Btk Ϫ , and Btk ϩ/Ϫ mice, without S17 stroma. Similar results were obtained in IL-7-driven BM cultures in the presence of S17 stromal cells, either throughout the 7-day culture period or from day 5 onwards (data not shown).
In these experiments, we used biotinylated Abs to detect sIgM expression, which resulted in higher fluorescence intensity values (up to 2 ϫ 10 3 ), as compared with the experiments described in Fig. 3 (up to 5 ϫ 10 2 ). We observed that most Btk Ϫ B220 ϩ cells stained with the anti-H chain Ab after culture with IL-7 (fluorescence intensities ranging from 20 to 100; Fig. 4A ). These cells were c positive, surface, or cytoplasmic or negative, and expressed SLC both in their cytoplasma and on the cell surface (see Results; Fig. 5 ). Therefore, we concluded that these cells were pre-B cells, and that the anti-H chain Ab staining in Btk Ϫ cells reflected high surface pre-BCR expression. In contrast, the Btk ϩ cells with anti-IgM fluorescence intensities ranging from 20 to 100 were surface ϩ cytoplasmic SLC Ϫ immature B cells (see Results; Fig. 5 ). When compared with Btk ϩ cultures, Btk Ϫ and Btk ϩ/Ϫ cultures were characterized by a more rapid loss of mature surface Ig ϩ cells (Fig. 4A, day 3) , and a reduced appearance of newly formed Ig ϩ B cells (Fig. 4A, days 5 and 7) . From the total cell counts and the flow cytometric analyses of the cells, the expansion rates of sIgM Ϫ and sIgM ϩ B220 ϩ cells during culture were calculated. As shown in Fig. 4B , pre-B cell expansion was significantly higher in the cultures from Btk Ϫ mice (ϳ30ϫ) when compared with Btk ϩ mice (Ͻ10ϫ). Only for Btk ϩ BM cells, the further differentiation of pre-B cells generated in the cultures in the presence of IL-7 resulted in an expansion of mature sIgM ϩ B cells (ϳ4ϫ). Increased proliferation of Btk Ϫ cells was confirmed by analysis of cell cycle and cell size (Fig. 4C) . After 5 days of culture, 53 Ϯ 3% of the Btk Ϫ cells (n ϭ 6) and only 25 Ϯ 3% of the Btk ϩ (n ϭ 6) were in the S, M, or G 2 phase of the cell cycle. In these experiments, the Btk Ϫ BM cultures contained higher proportions ( (Fig.  4, B-D) . At days 5 and 7, the surface Ig expression profiles and the FSC values in Btk ϩ/Ϫ cultures were similar to those of Btk Ϫ cells (Fig. 4, A and C 
Aberrant phenotype of Btk Ϫ cells in IL-7-driven BM cultures
Next, we investigated whether the inefficient pre-BCR-mediated induction of cell phenotype changes in Btk Ϫ pre-B and immature B cells in vivo were paralleled in the BM cultures in vitro. Large and small IgM Ϫ cells were obtained from total BM cultures in the presence of IL-7 for 7 days. Small IgM ϩ cells were obtained from total BM cell suspensions that were cultured in the presence of IL-7 for 5 days and subsequently in the absence of IL-7 on S17 stromal cells for 2 days. In agreement with our findings in vivo (Fig. 1) , we found by flow cytometric analysis that in Btk Ϫ cultures down-regulation of CD43 and up-regulation of CD2 and CD25 at the large to small pre-B cell transition was impaired (Fig.  5) . The expression of BP-1 was elevated in all three stages analyzed. Most importantly, we noticed that in the absence of Btk, SLC synthesis is not efficiently turned off, resulting in significantly enhanced cytoplasmic and surface SLC expression in Btk Ϫ large pre-B cells (96 Ϯ 1% and 29 Ϯ 2%, n ϭ 3, respectively), compared with 67 Ϯ 5% and 2.9 Ϯ 0.9% (n ϭ 3) in Btk ϩ cells. Also in small pre-B cells, cytoplasmic SLC expression was enhanced in Btk Ϫ cultures (62 Ϯ 5%), compared with Btk ϩ cultures (17 Ϯ 3%; Taken together, these findings in IL-7-driven BM cultures confirm the involvement of Btk signaling in the pre-BCR-mediated down-regulation of CD43 and SLC and the induction of CD2 and CD25 expression, and the initiation of Ig L chain rearrangements.
Btk Ϫ pro-B cells show significantly increased IL-7-driven proliferation in vitro
To investigate whether Btk-dependent modulation of IL-7 responsiveness in the mouse is specific for the pre-B cell stage, or alternatively, also occurs in earlier stages of B cell development, we crossed the Btk-deficient mice onto a RAG-1 Ϫ/Ϫ background. In these mice, B cell development is arrested at the CD43 ϩ pro-B cell stage, in which the BCR-linked CD79␣/CD79␤ heterodimers are expressed on the cell surface without associated H chains (39) . Btk ϩ and Btk Ϫ RAG-1 Ϫ/Ϫ mice contained similar numbers of CD43 ϩ B220 ϩ pro-B cells in vivo (data not shown), but the expression of IL-7R was slightly different (ϳ62% in Btk ϩ and ϳ79% in Btk Ϫ RAG-1 Ϫ/Ϫ mice). In [ 3 H]thymidine incorporation experiments, IL-7-induced proliferation was significantly enhanced in Btk Ϫ RAG-1 Ϫ/Ϫ pro-B cells, when compared with control Btk ϩ RAG-1 Ϫ/Ϫ pro-B cells (Fig. 6A) . Whereas we did not detect significant differences between the two groups of mice in the in vivo expression of the BP-1, the expression was elevated in the Btk Ϫ RAG-1 Ϫ/Ϫ BM cultures (Fig. 6B) . Collectively, these results indicate that Btk-signaling can modulate the responsiveness to IL-7 of early B cell precursors, even before pre-BCR expression.
Discussion
Btk and pre-BCR signaling
Signaling through the pre-BCR complex mediates the checkpoint function of H chain by inducing cell cycle entry and rapid downregulation of the rearrangement machinery, thereby ensuring allelic exclusion (14, 29) . Subsequently, the proliferating pre-B cells exit the cell cycle, change the expression profile of various cell surface markers, and perform Ig L chain rearrangements with sequential activation of the and the loci (14) . In humans, mutations in the Btk gene result in XLA, which reflects an almost complete block in B cell development at the pre-B cell stage (12, 13, 40 ). Similar to findings in mice deficient for the SLC component 5 or the membrane form of the Ig H chain (41, 42) , most XLA patients lack the compartment of large cycling pre-B cells (13) . Therefore, the XLA disease phenotype implicates Btk in the pre-BCR signaling-mediated expansion of those pre-B cells with a productive H chain rearrangement in humans.
In contrast, Btk is not essential for the selective expansion of c ϩ pre-B cells in the mouse, as in Btk-deficient mice the pre-B cell population is normal in size and contains normal proportions of cycling cells (16 -19) . In this report, we demonstrate that the mouse Btk is involved in later phases of pre-B cell differentiation. We compared the pre-B cell compartment in Btk ϩ mice and Btk As pre-B cell production in Btk Ϫ mice is normal, we conclude that the inefficient down-regulation of BP-1, CD43, and SLC ex- (14) that large c ϩ pre-B cells stop cycling when they run out of a sufficient number of assembled pre-BCR molecules per cell. This is not necessarily in conflict with our finding that the increased cytoplasmic SLC expression in Btk Ϫ pre-B cells did not result in increased proliferation in vivo. It is very possible that only the level of membrane SLC expression may correlate with the proliferative capacity of pre-B cells, and we were unable to detect differences between Btk ϩ and Btk Ϫ large pre-B cells in vivo in membrane SLC expression levels.
Btk and L chain rearrangement
We have previously found that Btk Ϫ mice show reduced L chain usage, which could either result from a defect in receptor editing or alternatively from a decreased rate or efficiency of L chain rearrangement (20) . Although by crossing 3-83 ␦ autoantibody transgenic mice into Btk Ϫ mice we have shown that Btk is not essential for receptor editing (20) , a possibility remained that the extent of L chain replacement events is reduced in Btk Ϫ mice. However, our BrdU-labeling experiments, in which we identified a 3-h delay at the small pre-B cell stage in Btk Ϫ mice, clearly argue against this possibility. Reduction of the level of receptor editing in Btk Ϫ mice would have the opposite effect of a more rapid transit through the small pre-B cell compartment, as B cells targeted for receptor editing were recently shown to be specifically delayed in this compartment for at least 2 h (33). Therefore, the finding of a 3-h delay supports a role for Btk in the regulation of the initiation of L chain rearrangement events. As both ϩ and ϩ Btk Ϫ cells are equally delayed, this cannot explain the observed reduced usage in Btk Ϫ mice (20) . However, we conclude that the absence of Btk specifically affects the production rate of ϩ immature B cells, as our linear regression analysis (Fig. 2C) In this context, it is unknown whether Btk signaling directly or indirectly regulates the activation of the L chain loci, or alternatively, whether Btk acts by mediating developmental progression to a pre-B cell stage in which L chain rearrangements are initiated. The latter possibility would be consistent with the delayed modulation of the expression of SLC, BP-1, CD43, CD2, and CD25. The finding that the expression of germline transcripts is first detected in vivo in large cycling CD25 ϩ pre-B cells would be consistent with a role for pre-BCR signaling the opening of the L chain loci for rearrangement (29, 43) . However, additional experiments would be needed to address this issue, as it has been shown that productive L chain rearrangement can also be induced by IL-7 withdrawal of pre-BCR-deficient 5 Ϫ/Ϫ or J H Ϫ/Ϫ pre-B cells in vitro (14, 44) .
The size of the immature B cell pool and the turnover of immature B cells were reported to be essentially normal in xid or Btk Ϫ mice (16 -18, 45) . Nevertheless, we previously observed a selective disadvantage of Btk Ϫ cells at the transition from pre-B cells to immature B cells in the BM, which we determined in an in vivo competition analysis in Btk ϩ/Ϫ heterozygous female mice (17) . In the immature B cell subset, we found lacZ expression values of ϳ30%, whereas in the absence of a competitive disadvantage, Btk Ϫ /lacZ ϩ cells would be expected to represent ϳ50% of any B cell subpopulation. The finding of a 3-h delay in production of immature B cells in Btk Ϫ mice would explain the observed selective disadvantage of Btk-deficient cells in Btk ϩ/Ϫ female mice.
Btk and IL-7 responsiveness
An inhibitory effect of Btk on proliferation of B-lineage cells in long-term Whitlock-Witte BM cultures has previously been reported (46) . However, analysis of growth kinetics of cultures established from mixtures of WT and xid cells indicated that the observed differences resulted from changes in the BM microenvironment associated with the xid mutation. In contrast, our separate analyses of lacZ ϩ and lacZ Ϫ cells in the BM cultures from Btk ϩ/Ϫ mice showed that increased IL-7 responsiveness is an intrinsic feature of Btk Ϫ pre-B cells. This would be consistent with the finding of an increased frequency of CFU responsive to IL-7 by limiting dilution analysis of day 15 fetal liver cells from CBA/N xid mice (47) .
Finally, crosses of Btk-deficient and RAG-1-deficient mice showed that IL-7-dependent expansion in vitro is constrained by an inhibitory signal mediated by Btk, even before the expression of H chain. Cross-linking of the Ig␤ signaling component of the (pre-)BCR, which is expressed on the cell surface in c Ϫ pro-B cells in association with calnexin induced a rapid phosphorylation of several intracellular signaling molecules, including Btk (22, 48) . Therefore, it is possible that Btk-mediated Ig␤/calnexin signaling would serve to stop pro-B cell proliferation to facilitate V(D)J recombination, which is exclusively initiated in the G 0 /G 1 cell cycle phase (49) . This hypothesis may be supported by a significant reduction of the level of V H to DJ H rearrangements observed in Ig␤-deficient mice (50) , which would then be explained by a reduced signal to make pro-B cells competent to undergo V H -DJ H rearrangement (48) . In this context, it has been shown previously that in later stages of B cell development, modulation of the IL-7 responsiveness is dependent on pre-BCR and BCR signaling (51, 52) . However, it is very possible that in pro-B cells, Btk may function in a pathway that is unrelated to the Ig␤/calnexin complex, as Btk has been implicated in signaling of various other receptors, including IL-5R, CD38, IL-10R, and Fc⑀RI (1, 2) .
Taken together, our findings implicate Btk in two different pathways in early B cell development. First, Btk is required for the efficient developmental progression of cytoplasmic ϩ pre-B cells, as Btk was shown to be involved in BP-1, CD43, and SLC downregulation, CD2 and CD25 up-regulation, and the rate of transit through the small pre-B cell compartment. Additional experiments are required to show whether Btk-mediated pre-BCR signaling directly or indirectly influences the expression of SLC, germline , or transcripts or the RAG genes. Second, the IL-7-driven BM culture experiments indicate a role for Btk as a pro-and pre-BCR associated negative regulator of IL-7 expansion. Although XLA patients may occasionally have a significantly increased pro-B cell compartment (12, 53) , in general there is no absolute pro-B expansion in XLA. Obviously, both in the mouse and in humans, other signaling molecules or pathways must be able to compensate for the loss of Btk in pro-B cells in vivo.
